Zoomposium 37 Tuesday 8 May (14:00-15:00)

Published: 5 April 2024

Dr Claire Marie Cisowski: ‘Light beyond two dimensions’ Dr Claire Bourke: ‘TITLE TBC’ Dr Helen Mulvana: ‘Development of novel ultrasound technologies towards earlier disease diagnosis and non-invasive treatments’

Speakers

  • Dr Claire Marie Cisowski, School of Physics & Astronomy
    ‘Light beyond two dimensions’
    The broad theme of my research is light structured in its polarisation and spatial degrees of freedom.  I am currently developing new design optimisation algorithms for integrated photonics and I am eager to connect with peers to explore how my research can be applied to bring new functionalities and/or improve the efficiency of current devices. I am also planning to apply for an EPSRC Open fellowship this summer to develop new tools to fully characterize nonparaxial light which naturally arises when light is strongly focused. I am keen to collaborate with colleagues to explore how my research can be exploited to enhance structural diagnostics. 
  • Dr Claire Bourke, School of Infection & Immunity (MVLS)
    'TITLE TBC'
    TEXT TBC.
  • Dr Helen Mulvana, James Watt School of Engineering
    ‘Development of novel ultrasound technologies towards earlier disease diagnosis and non-invasive treatments’
    My research aims to improve the prospects for individuals facing cancer, something which will affect one in two of us over the course of our lifetime. My group develops ultrasound technologies to pioneer novel, non-invasive tools for disease detection and treatment. My particular areas of expertise are in the use of ultrasound for therapeutic purposes to deliver non-invasive disease treatments, and in the development of micro and nanoscale ultrasound responsive particles that can enhance ultrasound therapies, or reveal otherwise hidden information about tissue physiology and local microstructure during ultrasound imaging. The aim is to improve sensitivity of disease detection for earlier diagnoses, non-invasive staging and reduced reliance on painful tissue biopsy, and to develop point of care treatments that can accelerate recovery.

First published: 5 April 2024